Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
ACS Infectious Diseases|January 8, 2021
Early Returns on Small Molecule Therapeutics for SARS-CoV-2Mark N NamchukACS Medicinal Chemistry Letters|November 17, 2022
Advancing New Chemical Modalities into Clinical StudiesMaria-Jesus Blanco, Kevin M Gardinier, Mark N NamchukClinical and Translational Science|August 5, 2022
A review of clinical efficacy data supporting emergency use authorization for COVID-19 therapeutics and lessons for future pandemicsSeo-Hyun Yoo, Lauren Kim, Michelle Lu, et al.ACS Infectious Diseases|August 26, 2021
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main ProteaseElizabeth A MacDonald, Gary Frey, Mark N Namchuk, et al.The Journal of Pharmacology and Experimental Therapeutics|August 16, 2018
In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive DisorderJean M Bidlack, Brian I Knapp, Daniel R Deaver, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 10, 2021
Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteersFrederico G S Toledo, William F Martin, Linda Morrow, et al.Journal of Medicinal Chemistry|February 16, 2007
Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitorsAlex M Aronov, Christopher Baker, Guy W Bemis, et al.Iscience|July 14, 2025
Inhibition of dimeric SARS-CoV-2 Mpro displays positive cooperativity and a mixture of covalent and non-covalent bindingKrishna M Padmanabha Das, Jun Chen, Paul S Charifson, et al.Journal of Medicinal Chemistry|October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational controlAlex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.Pageof 2